UPDATE: Hintermann Series H3 Total Ankle Replacement Has a Higher-Than-Expected Risk of Device Failure: FDA Safety Communication
FDA warns that Hintermann Series H3 Total Ankle Replacement has higher-than-expected failure risk. While not directly related to med-spa services, clinics offering orthopedic procedures should review patient communications and device monitoring.
Aforeworn detected this change in the Med-Spa & Aesthetics Clinics space on July 6, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Med-spa clinics that perform or refer for total ankle replacement procedures should confirm how it applies to their specific situation before acting. There is a time constraint attached: Ongoing; no specific deadline but prompt action advised. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Med-Spa & Aesthetics Clinics continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
FDA updated safety communication indicating increased failure risk for Hintermann Series H3 TAR
Who it affects
Med-spa clinics that perform or refer for total ankle replacement procedures
What you must do
Review inventory for Hintermann Series H3 devices; inform affected patients; follow FDA recommendations
Deadline
Ongoing; no specific deadline but prompt action advised
Never miss a change like this again
Aforeworn watches Med-Spa & Aesthetics Clinics around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Med-Spa & Aesthetics Clinics
- FDA Approves Labeling Changes for Over-the-Counter (OTC) Weight Loss Drug alli (Orlistat) to Warn of Risk of Kidney Stones and Kidney Injury
- Accolade Pacemaker Devices by Boston Scientific and Potential Need for Early Device Replacement - FDA Safety Communication
- Heart Pump Correction: Abiomed Issues Correction for Automated Impella Controllers
- Disruptions in Availability of Breast Biopsy Needles - Letter to Health Care Providers
- The Safer Affordable Fuel-Efficient (SAFE) Vehicles Rule for Model Years 2021-2026 Passenger Cars and Light Trucks